Third Harmonic Bio Analyst Ratings
Third Harmonic Bio Analyst Ratings
While ratings are subjective and will change, the latest Third Harmonic Bio (THRD) rating was a maintained with a price target of $5.00 to $7.00. The current price Third Harmonic Bio (THRD) is trading at is $6.24, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/11/2023 | 12.18% | Morgan Stanley | $5 → $7 | Maintains | Equal-Weight |
| 12/16/2022 | -19.87% | Morgan Stanley | $34 → $5 | Downgrades | Overweight → Equal-Weight |
| 12/16/2022 | -42.31% | Jefferies | $30 → $3.6 | Downgrades | Buy → Hold |
| 10/10/2022 | 380.77% | Jefferies | → $30 | Initiates Coverage On | → Buy |
| 10/10/2022 | 444.87% | Morgan Stanley | → $34 | Initiates Coverage On | → Overweight |
| 10/10/2022 | — | Cowen & Co. | Initiates Coverage On | → Outperform |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 08/11/2023 | 12.18% | 摩根士丹利 | 5 美元 → 7 美元 | 维护 | 重量相等 |
| 2022 年 12 月 16 日 | -19.87% | 摩根士丹利 | 34 美元 → 5 美元 | 降级 | 超重 → 重量相等 |
| 2022 年 12 月 16 日 | -42.31% | 杰富瑞 | 30 美元 → 3.6 美元 | 降级 | 买入 → 持有 |
| 2022 年 10 月 10 日 | 380.77% | 杰富瑞 | → 30 美元 | 启动覆盖开启 | → 购买 |
| 2022 年 10 月 10 日 | 444.87% | 摩根士丹利 | → 34 美元 | 启动覆盖开启 | → 超重 |
| 2022 年 10 月 10 日 | — | Cowen & Co. | 启动覆盖开启 | → 跑赢大盘 |
What is the target price for Third Harmonic Bio (THRD)?
三谐波生物（THRD）的目标价格是多少？
The latest price target for Third Harmonic Bio (NASDAQ: THRD) was reported by Morgan Stanley on August 11, 2023. The analyst firm set a price target for $7.00 expecting THRD to rise to within 12 months (a possible 12.18% upside). 6 analyst firms have reported ratings in the last year.
摩根士丹利于2023年8月11日公布了第三谐波生物（纳斯达克股票代码：THRD）的最新目标股价。该分析公司将目标股价定为7.00美元，预计THRD将在12个月内上涨至12.18％（可能上涨12.18％）。去年有6家分析公司公布了评级。
What is the most recent analyst rating for Third Harmonic Bio (THRD)?
分析师对Third Harmonic Bio（THRD）的最新评级是多少？
The latest analyst rating for Third Harmonic Bio (NASDAQ: THRD) was provided by Morgan Stanley, and Third Harmonic Bio maintained their equal-weight rating.
第三谐波生物（纳斯达克股票代码：THRD）的最新分析师评级由摩根士丹利提供，Third Harmonic Bio维持同等权重评级。
When is the next analyst rating going to be posted or updated for Third Harmonic Bio (THRD)?
Third Harmonic Bio（THRD）的下一个分析师评级何时公布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Third Harmonic Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Third Harmonic Bio was filed on August 11, 2023 so you should expect the next rating to be made available sometime around August 11, 2024.
分析师在进行了广泛的研究后得出了股票评级，包括阅读公开财务报表、与Third Harmonic Bio的高管和客户交谈以及听取财报电话会议。大多数分析师每三个月进行一次评级，因此每家公司每年应获得4个评级。Third Harmonic Bio的最后一次评级是在2023年8月11日提交的，因此你应该预计下一个评级将在2024年8月11日左右公布。
Is the Analyst Rating Third Harmonic Bio (THRD) correct?
分析师对三谐波生物（THRD）的评级正确吗？
While ratings are subjective and will change, the latest Third Harmonic Bio (THRD) rating was a maintained with a price target of $5.00 to $7.00. The current price Third Harmonic Bio (THRD) is trading at is $6.24, which is within the analyst's predicted range.
尽管评级是主观的，并且会发生变化，但最新的第三谐波生物（THRD）评级保持不变，目标价为5.00美元至7.00美元。Third Harmonic Bio（THRD）目前的交易价格为6.24美元，在分析师的预测区间内。
